CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 16 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $31,000 | -71.3% | 81,343 | -50.0% | 0.00% | – |
| Q4 2019 | $108,000 | +237.5% | 162,686 | +100.0% | 0.00% | – |
| Q3 2019 | $32,000 | -25.6% | 81,343 | 0.0% | 0.00% | – |
| Q2 2019 | $43,000 | +115.0% | 81,343 | +275.0% | 0.00% | – |
| Q1 2019 | $20,000 | -23.1% | 21,692 | -50.0% | 0.00% | – |
| Q4 2018 | $26,000 | -10.3% | 43,384 | +100.0% | 0.00% | – |
| Q3 2018 | $29,000 | -3.3% | 21,692 | 0.0% | 0.00% | – |
| Q2 2018 | $30,000 | +3.4% | 21,692 | 0.0% | 0.00% | – |
| Q1 2018 | $29,000 | -21.6% | 21,692 | 0.0% | 0.00% | – |
| Q4 2017 | $37,000 | -5.1% | 21,692 | 0.0% | 0.00% | – |
| Q3 2017 | $39,000 | -52.4% | 21,692 | 0.0% | 0.00% | – |
| Q2 2017 | $82,000 | +17.1% | 21,692 | +53.9% | 0.00% | – |
| Q2 2016 | $70,000 | – | 14,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 559,900 | $2,111,000 | 0.75% |
| WEDBUSH SECURITIES INC | 13,900 | $52,000 | 0.01% |
| MinichMacGregor Wealth Management, LLC | 800 | $3,000 | 0.00% |
| UBS Group AG | 180 | $1,000 | 0.00% |
| D'Orazio & Associates, Inc. | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 30,913 | $117,000 | 0.00% |
| Parallel Advisors, LLC | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,692 | $82,000 | 0.00% |
| DEUTSCHE BANK AG\ | 2,403 | $9,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 10,346 | $39,000 | 0.00% |